Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in Clin Cardiol

Retrieve available abstracts of 102 articles:
HTML format
Text format



Single Articles


    March 2018
  1. LI SN, Wang L, Dong JZ, Yu RH, et al
    Electrocardiographic Left Ventricular Hypertrophy Predicts Recurrence of Atrial Arrhythmias after Catheter Ablation of Paroxysmal Atrial Fibrillation.
    Clin Cardiol. 2018 Mar 31. doi: 10.1002/clc.22957.
    PubMed     Text format     Abstract available


  2. SHI R, Li ZH, Chen D, Wu QC, et al
    Sole and combined vitamin C supplementation can prevent postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.
    Clin Cardiol. 2018 Mar 30. doi: 10.1002/clc.22951.
    PubMed     Text format     Abstract available


  3. KHEIRBEK RE, Fokar A, Moore HJ, Shara N, et al
    Association between Lifetime Risk of Atrial Fibrillation and Mortality in the Oldest Old.
    Clin Cardiol. 2018 Mar 22. doi: 10.1002/clc.22941.
    PubMed     Text format     Abstract available


  4. BUCHHOLZ A, Ueberham L, Gorczynska K, Dinov B, et al
    Initial Apixaban Dosing in Patients with Atrial Fibrillation.
    Clin Cardiol. 2018 Mar 15. doi: 10.1002/clc.22949.
    PubMed     Text format     Abstract available


  5. MCINTYRE WF, Conen D, Olshansky B, Halperin JL, et al
    Stroke prevention strategies in North American patients with atrial fibrillation: the GLORIA-AF registry program.
    Clin Cardiol. 2018 Mar 15. doi: 10.1002/clc.22936.
    PubMed     Text format     Abstract available


  6. MARTIN AC, Lessire S, Leblanc I, Dincq AS, et al
    Peri-procedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant-treated patients.
    Clin Cardiol. 2018 Mar 13. doi: 10.1002/clc.22944.
    PubMed     Text format     Abstract available


  7. OFMAN P, Hoffmeister P, Kaloupek DG, Gagnon DR, et al
    Posttraumatic stress disorder and mortality in VA patients with implantable cardioverter defibrillator.
    Clin Cardiol. 2018 Mar 13. doi: 10.1002/clc.22945.
    PubMed     Text format     Abstract available


  8. SADEK MM, Chaugai V, Cleland MJ, Zakutney TJ, et al
    Association between transthoracic impedance and electrical cardioversion success with biphasic defibrillators: an analysis of 1,055 shocks for atrial fibrillation and flutter.
    Clin Cardiol. 2018 Mar 13. doi: 10.1002/clc.22947.
    PubMed     Text format     Abstract available


  9. LI X, Gao L, Wang Z, Guan B, et al
    Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China.
    Clin Cardiol. 2018;41:314-320.
    PubMed     Text format     Abstract available


  10. MOREL E, Manati AW, Nony P, Maucort-Boulch D, et al
    Blockade of the renin-angiotensin-aldosterone system in patients with arrhythmogenic right ventricular dysplasia: A double-blind, multicenter, prospective, randomized, genotype-driven study (BRAVE study).
    Clin Cardiol. 2018;41:300-306.
    PubMed     Text format     Abstract available


  11. XU B, Dobson L, Mottram PM, Nasis A, et al
    Is exercise stress echocardiography useful in patients with suspected obstructive coronary artery disease who have resting left bundle branch block?
    Clin Cardiol. 2018;41:360-365.
    PubMed     Text format     Abstract available


  12. COSANSU K, Vatan MB, Gunduz H, Akdemir R, et al
    Use of neutrophil-lymphocyte ratio for risk stratification and relationship with time in therapeutic range in patients with nonvalvular atrial fibrillation: A pilot study.
    Clin Cardiol. 2018;41:339-342.
    PubMed     Text format     Abstract available


  13. WEIJS B, Limantoro I, Delhaas T, de Vos CB, et al
    Cardioversion of persistent atrial fibrillation is associated with a 24-hour relapse gap: Observations from prolonged postcardioversion rhythm monitoring.
    Clin Cardiol. 2018;41:366-371.
    PubMed     Text format     Abstract available


  14. SANNA T, Ziegler PD, Crea F
    Detection and management of atrial fibrillation after cryptogenic stroke or embolic stroke of undetermined source.
    Clin Cardiol. 2018;41:426-432.
    PubMed     Text format     Abstract available


    February 2018
  15. HOLL MJ, van den Bos EJ, van Domburg RT, Fouraux MA, et al
    NT-proBNP is associated with mortality and adverse cardiac events in patients with atrial fibrillation presenting to the emergency department.
    Clin Cardiol. 2018 Feb 26. doi: 10.1002/clc.22883.
    PubMed     Text format     Abstract available


  16. AN K, Zhu J, Ma N, Tang M, et al
    Predictive risk factors for recurrent atrial fibrillation after modified endoscopic ablation: A 2-year follow-up.
    Clin Cardiol. 2018 Feb 26. doi: 10.1002/clc.22878.
    PubMed     Text format     Abstract available


  17. KOCHAR A, Hellkamp AS, Lokhnygina Y, Jones WS, et al
    Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial.
    Clin Cardiol. 2018 Feb 1. doi: 10.1002/clc.22846.
    PubMed     Text format     Abstract available


    January 2018
  18. HU XF, Zhan R, Xu S, Wang J, et al
    Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
    Clin Cardiol. 2018 Jan 24. doi: 10.1002/clc.22844.
    PubMed     Text format     Abstract available


  19. COLEMAN CI, Vaitsiakhovich T, Nguyen E, Weeda ER, et al
    Agreement between coding schemas used to identify bleeding-related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients.
    Clin Cardiol. 2018 Jan 23. doi: 10.1002/clc.22861.
    PubMed     Text format     Abstract available


  20. BAZOUKIS G, Letsas KP, Tse G, Naka KK, et al
    Predictors of arrhythmia recurrence in patients with heart failure undergoing left atrial ablation for atrial fibrillation.
    Clin Cardiol. 2018 Jan 22. doi: 10.1002/clc.22850.
    PubMed     Text format     Abstract available


  21. WUEST S, Twerenbold R, Kuhne M, Reichlin T, et al
    Reassessment of cardiovascular parameters and comorbidities in implantable cardioverter-defibrillator patients at the time of first replacement.
    Clin Cardiol. 2018 Jan 22. doi: 10.1002/clc.22849.
    PubMed     Text format     Abstract available


    December 2017
  22. WEE XT, Ho LM, Ho HK, Lee JY, et al
    Incidence of thromboembolic and bleeding events in patients with newly diagnosed nonvalvular atrial fibrillation: An Asian multicenter retrospective cohort study in Singapore.
    Clin Cardiol. 2017 Dec 18. doi: 10.1002/clc.22811.
    PubMed     Text format     Abstract available


  23. AACHI RV, Birnbaum LA, Topel CH, Seifi A, et al
    Laboratory characteristics of ischemic stroke patients with atrial fibrillation on or off therapeutic warfarin.
    Clin Cardiol. 2017 Dec 18. doi: 10.1002/clc.22838.
    PubMed     Text format     Abstract available


  24. HUANG X, Chen Y, Huang Y, Zhao H, et al
    Clinical efficacy of irrigated catheter application of amiodarone during ablation of persistent atrial fibrillation.
    Clin Cardiol. 2017 Dec 16. doi: 10.1002/clc.22835.
    PubMed     Text format     Abstract available


  25. VRSALOVIC M, Presecki AV
    Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: A meta-analysis of prospective studies.
    Clin Cardiol. 2017 Dec 15. doi: 10.1002/clc.22813.
    PubMed     Text format     Abstract available


  26. LAHTELA HM, Bah A, Kiviniemi T, Nammas W, et al
    Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.
    Clin Cardiol. 2017 Dec 15. doi: 10.1002/clc.22821.
    PubMed     Text format     Abstract available


  27. EHLERT AN, Heckbert SR, Wiggins KL, Thacker EL, et al
    Administrative billing codes accurately identified occurrence of electrical cardioversion and ablation/maze procedures in a prospective cohort study of atrial fibrillation patients.
    Clin Cardiol. 2017 Dec 6. doi: 10.1002/clc.22812.
    PubMed     Text format     Abstract available


    September 2017
  28. AKIROV A, Grossman A, Shochat T, Shimon I, et al
    Hyperglycemia on admission and hospitalization outcomes in patients with atrial fibrillation.
    Clin Cardiol. 2017 Sep 12. doi: 10.1002/clc.22801.
    PubMed     Text format     Abstract available


    August 2017
  29. LU R, Ma N, Jiang Z, Mei J, et al
    Hemodynamic parameters predict the risk of atrial fibrillation after cardiac surgery in adults.
    Clin Cardiol. 2017 Aug 29. doi: 10.1002/clc.22783.
    PubMed     Text format     Abstract available


  30. SHEN K, Tu T, Yuan Z, Yi J, et al
    DNA methylation dysregulations in valvular atrial fibrillation.
    Clin Cardiol. 2017 Aug 28. doi: 10.1002/clc.22715.
    PubMed     Text format     Abstract available


  31. TSCHOLL V, Lsharaf AK, Lin T, Bellmann B, et al
    Apixaban, rivaroxaban, and dabigatran use in patients undergoing catheter ablation for atrial fibrillation using the second-generation cryoballoon.
    Clin Cardiol. 2017 Aug 28. doi: 10.1002/clc.22782.
    PubMed     Text format     Abstract available


  32. ANDERSSON T, Magnuson A, Bryngelsson IL, Frobert O, et al
    Patients without comorbidities at the time of diagnosis of atrial fibrillation: causes of death during long-term follow-up compared to matched controls.
    Clin Cardiol. 2017 Aug 25. doi: 10.1002/clc.22776.
    PubMed     Text format     Abstract available


  33. YANG Y, Han X, Chen Y, Gao L, et al
    Association between modifiable lifestyle and the prevalence of atrial fibrillation in a Chinese population: Based on the cardiovascular health score.
    Clin Cardiol. 2017 Aug 21. doi: 10.1002/clc.22771.
    PubMed     Text format     Abstract available


  34. CHOI SW, Kim BB, Choi DH, Park G, et al
    Stroke or left atrial thrombus prediction using antithrombin III and mean platelet volume in patients with nonvalvular atrial fibrillation.
    Clin Cardiol. 2017 Aug 14. doi: 10.1002/clc.22759.
    PubMed     Text format     Abstract available


  35. KAPLAN RM, Ziegler PD, Koehler J, Glotzer TV, et al
    Atrial fibrillation variability on long-term monitoring of implantable cardiac rhythm management devices.
    Clin Cardiol. 2017 Aug 11. doi: 10.1002/clc.22766.
    PubMed     Text format     Abstract available


  36. OWENS RE, Kabra R, Oliphant CS
    Edoxaban Use in Nonvalvular Atrial Fibrillation With Valvular Heart Disease-Insights from ENGAGE AF-TIMI 48.
    Clin Cardiol. 2017;40:612-613.
    PubMed     Text format    


    July 2017
  37. BAJWA RJ, Kovell L, Resar JR, Arbab-Zadeh A, et al
    Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Clin Cardiol. 2017 Jul 27. doi: 10.1002/clc.22764.
    PubMed     Text format     Abstract available


  38. LEMESLE G, Ducrocq G, Elbez Y, Van Belle E, et al
    Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
    Clin Cardiol. 2017 Jul 10. doi: 10.1002/clc.22750.
    PubMed     Text format     Abstract available


    June 2017
  39. ARANA-RUEDA E, Pedrote A, Frutos-Lopez M, Acosta J, et al
    Repeated procedures at the generator pocket are a determinant of implantable cardioverter-defibrillator infection.
    Clin Cardiol. 2017 Jun 21. doi: 10.1002/clc.22743.
    PubMed     Text format     Abstract available


  40. SHULMAN E, Kargoli F, Aagaard P, Hoch E, et al
    Socioeconomic status and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic whites.
    Clin Cardiol. 2017 Jun 9. doi: 10.1002/clc.22732.
    PubMed     Text format     Abstract available


  41. N GIGLIOTTI J, Sidhu MS, Robert AM, Zipursky JS, et al
    The association of QRS duration with atrial fibrillation in a heart failure with preserved ejection fraction population: a pilot study.
    Clin Cardiol. 2017 Jun 6. doi: 10.1002/clc.22736.
    PubMed     Text format     Abstract available


    May 2017
  42. VLACHOS K, Efremidis M, Bazoukis G, Letsas KP, et al
    Safety and efficacy of DOACs vs acenocoumarol in patients undergoing catheter ablation of atrial fibrillation.
    Clin Cardiol. 2017 May 31. doi: 10.1002/clc.22734.
    PubMed     Text format     Abstract available


  43. HAN X, Yang Y, Chen Y, Gao L, et al
    Association between insomnia and atrial fibrillation in a Chinese population: A cross-sectional study.
    Clin Cardiol. 2017 May 31. doi: 10.1002/clc.22731.
    PubMed     Text format     Abstract available


  44. MANOLIS AS, Maounis T, Koulouris S, Vassilikos V, et al
    "Real life" longevity of implantable cardioverter-defibrillator devices.
    Clin Cardiol. 2017 May 22. doi: 10.1002/clc.22729.
    PubMed     Text format     Abstract available


  45. BLACK-MAIER E, Kim S, Steinberg BA, Fonarow GC, et al
    Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
    Clin Cardiol. 2017 May 19. doi: 10.1002/clc.22726.
    PubMed     Text format     Abstract available


  46. MULDER BA, Damman K, Van Veldhuisen DJ, Van Gelder IC, et al
    Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
    Clin Cardiol. 2017 May 17. doi: 10.1002/clc.22725.
    PubMed     Text format     Abstract available


  47. LILLI A, Di Cori A, Zaca V
    Thromboembolic risk and effect of oral anticoagulation according to atrial fibrillation patterns: A systematic review and meta-analysis.
    Clin Cardiol. 2017 May 4. doi: 10.1002/clc.22701.
    PubMed     Text format     Abstract available


    April 2017
  48. MARTINEZ-SELLES M, Baranchuk A, Elosua R, de Luna AB, et al
    Rationale and design of the BAYES (Interatrial Block and Yearly Events) registry.
    Clin Cardiol. 2017;40:196-199.
    PubMed     Text format     Abstract available


    March 2017
  49. DUNCKER D, Konig T, Hohmann S, Bauersachs J, et al
    Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study.
    Clin Cardiol. 2017 Mar 23. doi: 10.1002/clc.22706.
    PubMed     Text format     Abstract available


  50. HASSAN VIRK HU, Qureshi WT, Makkar N, Bastawrose J, et al
    Short- and long-term clinical predictors of pharmacological cardioversion of persistent atrial fibrillation by dofetilide: A retrospective cohort study of 160 patients.
    Clin Cardiol. 2017 Mar 14. doi: 10.1002/clc.22680.
    PubMed     Text format     Abstract available


  51. MAZZA A, Bendini MG, De Cristofaro R, Lovecchio M, et al
    Prevalence and clinical significance of left bundle branch block according to classical or strict definition criteria in permanent pacemaker patients.
    Clin Cardiol. 2017 Mar 10. doi: 10.1002/clc.22673.
    PubMed     Text format     Abstract available


  52. DILAVERIS PE, Kennedy HL
    Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact.
    Clin Cardiol. 2017 Mar 8. doi: 10.1002/clc.22667.
    PubMed     Text format     Abstract available


  53. VALLURUPALLI S, Shanbhag A, Mehta JL
    Controversies in postoperative atrial fibrillation after noncardiothoracic surgery: clinical and research implications.
    Clin Cardiol. 2017 Mar 8. doi: 10.1002/clc.22652.
    PubMed     Text format     Abstract available


  54. SENNHAUSER S, Anand R, Kusumoto F, Goldschlager N, et al
    Heart Rhythm Society: expert consensus statements-part 2.
    Clin Cardiol. 2017;40:186-190.
    PubMed     Text format     Abstract available


  55. SENNHAUSER S, Anand R, Kusumoto F, Goldschlager N, et al
    Heart Rhythm Society: expert consensus statements-part 1.
    Clin Cardiol. 2017;40:177-185.
    PubMed     Text format     Abstract available


    February 2017
  56. LI JY, He Y, Ke HH, Jin Y, et al
    Plasma oxidative stress and inflammatory biomarkers are associated with the sizes of the left atrium and pulmonary vein in atrial fibrillation patients.
    Clin Cardiol. 2017 Feb 16. doi: 10.1002/clc.22633.
    PubMed     Text format     Abstract available


  57. VENKATESH S, O'Neal WT, Broughton ST, Shah AJ, et al
    The clinical utility of normal findings on noninvasive cardiac assessment in the prediction of atrial fibrillation.
    Clin Cardiol. 2017 Feb 13. doi: 10.1002/clc.22644.
    PubMed     Text format     Abstract available


  58. TREVISAN C, Maggi S, Curreri C, Nante G, et al
    Anthropometric parameters and the incidence of atrial fibrillation in older people: the PRO.V.A study.
    Clin Cardiol. 2017 Feb 13. doi: 10.1002/clc.22677.
    PubMed     Text format     Abstract available


  59. LI W, Li S, Li X, Jiang S, et al
    Interleukin-37 elevation in patients with atrial fibrillation.
    Clin Cardiol. 2017;40:66-72.
    PubMed     Text format     Abstract available


  60. ZUO K, Sun L, Yang X, Lyu X, et al
    Correlation between cardiac rhythm, left atrial appendage flow velocity, and CHA2 DS2 -VASc score: Study based on transesophageal echocardiography and 2-dimensional speckle tracking.
    Clin Cardiol. 2017;40:120-125.
    PubMed     Text format     Abstract available


    January 2017
  61. YIN K, Ding L, Li Y, Hua W, et al
    Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Clin Cardiol. 2017 Jan 31. doi: 10.1002/clc.22648.
    PubMed     Text format     Abstract available


  62. LEE BC, Ruiz-Cordell KD, Haimowitz SM, Williams C, et al
    Personalized, assessment-based, and tiered medical education curriculum integrating treatment guidelines for atrial fibrillation.
    Clin Cardiol. 2017 Jan 31. doi: 10.1002/clc.22676.
    PubMed     Text format     Abstract available


  63. BALOUCH M, Gucuk Ipek E, Chrispin J, Bajwa RJ, et al
    Impact of rotor temperospatial stability on acute and one-year atrial fibrillation ablation outcomes.
    Clin Cardiol. 2017 Jan 25. doi: 10.1002/clc.22674.
    PubMed     Text format     Abstract available


    December 2016
  64. OWENS RE, Kabra R, Oliphant CS
    Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review.
    Clin Cardiol. 2016 Dec 22. doi: 10.1002/clc.22659.
    PubMed     Text format     Abstract available


  65. GEORGIOPOULOS G, Tsiachris D, Manolis AS
    Cryoballoon ablation of atrial fibrillation: a practical and effective approach.
    Clin Cardiol. 2016 Dec 19. doi: 10.1002/clc.22653.
    PubMed     Text format     Abstract available


  66. EREZ A, Goldenberg I, Sabbag A, Nof E, et al
    Temporal trends and outcomes associated with atrial fibrillation observed during acute coronary syndrome: Real-world data from the Acute Coronary Syndrome Israeli Survey (ACSIS), 2000-2013.
    Clin Cardiol. 2016 Dec 5. doi: 10.1002/clc.22654.
    PubMed     Text format     Abstract available


  67. WANG Z, Zhang H, Peng H, Shen X, et al
    Voltage combined with pace mapping is simple and effective for ablation of noninducible premature ventricular contractions originating from the right ventricular outflow tract.
    Clin Cardiol. 2016;39:733-738.
    PubMed     Text format     Abstract available


    November 2016
  68. LI WH, Huang D, Chiang CE, Lau CP, et al
    Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project.
    Clin Cardiol. 2016 Nov 28. doi: 10.1002/clc.22649.
    PubMed     Text format     Abstract available


  69. CHEN XM, Ji CC, Cheng YJ, Liu LJ, et al
    The Role of the Ratio of J-Point Elevation Magnitude and R-Wave Amplitude on the Same ECG Lead in the Risk Stratification of Subjects With Early Repolarization Pattern.
    Clin Cardiol. 2016;39:678-683.
    PubMed     Text format     Abstract available


    October 2016
  70. KOSIUK J, Milani R, Ueberham L, Uhe T, et al
    Effect of remote ischemic preconditioning on electrophysiological and biomolecular parameters in nonvalvular paroxysmal atrial fibrillation (RIPPAF study): Rationale and study design of a randomized, controlled clinical trial.
    Clin Cardiol. 2016 Oct 24. doi: 10.1002/clc.22584.
    PubMed     Text format     Abstract available


  71. WANG RX, Lee HC, Li JP, Hodge DO, et al
    Sudden death and its risk factors after atrioventricular junction ablation and pacemaker implantation in patients with atrial fibrillation.
    Clin Cardiol. 2016 Oct 17. doi: 10.1002/clc.22600.
    PubMed     Text format     Abstract available


  72. OKUMURA K, Hori M, Tanahashi N, John Camm A, et al
    Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation.
    Clin Cardiol. 2016 Oct 7. doi: 10.1002/clc.22596.
    PubMed     Text format     Abstract available


  73. UETAKE S, Maruyama M, Yamamoto T, Kato K, et al
    Left ventricular stiffness estimated by diastolic wall strain is associated with paroxysmal atrial fibrillation in structurally normal hearts.
    Clin Cardiol. 2016 Oct 7. doi: 10.1002/clc.22595.
    PubMed     Text format     Abstract available


  74. UROOJ F, Kulkarni A, Stapleton D, Kaluski E, et al
    New Oral Anticoagulants in Nonvalvular Atrial Fibrillation.
    Clin Cardiol. 2016 Oct 7. doi: 10.1002/clc.22582.
    PubMed     Text format     Abstract available


  75. BUCKLEY LF, Rybak E, Aldemerdash A, Cheng JW, et al
    Direct oral anticoagulants in patients with atrial fibrillation and renal impairment, extremes in weight, or advanced age.
    Clin Cardiol. 2016 Oct 7. doi: 10.1002/clc.22591.
    PubMed     Text format     Abstract available


  76. COLEMAN CI, Haas S, Turpie AG, Kuhls S, et al
    Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS Substudy.
    Clin Cardiol. 2016;39:565-569.
    PubMed     Text format     Abstract available


    September 2016
  77. ZHAO S, Chen K, Su Y, Hua W, et al
    High incidence of ventricular arrhythmias in patients with left ventricular enlargement and moderate left ventricular dysfunction.
    Clin Cardiol. 2016 Sep 9. doi: 10.1002/clc.22588.
    PubMed     Text format     Abstract available


    August 2016
  78. CANNON CP, Gropper S, Bhatt DL, Ellis SG, et al
    Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibr
    Clin Cardiol. 2016 Aug 26. doi: 10.1002/clc.22572.
    PubMed     Text format     Abstract available


  79. ZHANG Z, Yang Y, Ng CY, Wang D, et al
    Meta-analysis of Vitamin D Deficiency and Risk of Atrial Fibrillation.
    Clin Cardiol. 2016 Aug 24. doi: 10.1002/clc.22563.
    PubMed     Text format     Abstract available


  80. O'NEAL WT, Qureshi WT, Nazarian S, Kawel-Boehm N, et al
    Electrocardiographic Time to Intrinsicoid Deflection and Heart Failure: The Multi-Ethnic Study of Atherosclerosis.
    Clin Cardiol. 2016 Aug 23. doi: 10.1002/clc.22561.
    PubMed     Text format     Abstract available


  81. TANBOGA IH, Topcu S, Aksakal E, Gulcu O, et al
    The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients.
    Clin Cardiol. 2016 Aug 11. doi: 10.1002/clc.22578.
    PubMed     Text format     Abstract available


    July 2016
  82. JACKSON LR 2ND, Piccini JP, Cyr DD, Roe MT, et al
    Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.
    Clin Cardiol. 2016 Jul 28. doi: 10.1002/clc.22562.
    PubMed     Text format     Abstract available


  83. ANDO T, Takagi H
    The Prognostic Impact of New-Onset Persistent Left Bundle Branch Block Following Transcatheter Aortic Valve Implantation: A Meta-analysis.
    Clin Cardiol. 2016 Jul 19. doi: 10.1002/clc.22567.
    PubMed     Text format     Abstract available


    June 2016
  84. KANDZARI DE, Perumal R, Bhatt DL
    Frequency and Implications of Ischemia Prior to Ventricular Tachyarrhythmia in Patients Treated With a Wearable Cardioverter Defibrillator Following Myocardial Infarction.
    Clin Cardiol. 2016 Jun 24. doi: 10.1002/clc.22544.
    PubMed     Text format     Abstract available


    May 2016
  85. PALOMAKI A, Kiviniemi T, Hartikainen JE, Mustonen P, et al
    Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.
    Clin Cardiol. 2016 May 30. doi: 10.1002/clc.22554.
    PubMed     Text format     Abstract available


  86. ZHU W, Shen Y, Zhou Q, Xu Z, et al
    Association of Physical Fitness With the Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Clin Cardiol. 2016 May 13. doi: 10.1002/clc.22552.
    PubMed     Text format     Abstract available


  87. CORTEZ D, Graw S, Mestroni L
    In Hypertrophic Cardiomyopathy, the Spatial Peaks QRS-T Angle Identifies Those With Sustained Ventricular Arrhythmias.
    Clin Cardiol. 2016 May 13. doi: 10.1002/clc.22549.
    PubMed     Text format     Abstract available


  88. OSMANAGIC A, Moller S, Osmanagic A, Sheta HM, et al
    Left Atrial Sphericity Index Predicts Early Recurrence of Atrial Fibrillation After Direct-Current Cardioversion: An Echocardiographic Study.
    Clin Cardiol. 2016 May 10. doi: 10.1002/clc.22545.
    PubMed     Text format     Abstract available


  89. SAWATARI H, Ohkusa T, Rahamawati A, Ishikawa K, et al
    Left Ventricular Ejection Fraction Predicts Severity of Posttraumatic Stress Disorder in Patients With Implantable Cardioverter-Defibrillators.
    Clin Cardiol. 2016 May 6. doi: 10.1002/clc.22521.
    PubMed     Text format     Abstract available


    March 2016
  90. EXPOSITO V, Rodriguez-Entem F, Gonzalez-Enriquez S, Veiga G, et al
    Stroke and Systemic Embolism After Successful Ablation of Typical Atrial Flutter.
    Clin Cardiol. 2016 Mar 30. doi: 10.1002/clc.22538.
    PubMed     Text format     Abstract available


  91. PLITT A, Ezekowitz MD, De Caterina R, Nordio F, et al
    Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Clin Cardiol. 2016 Mar 30. doi: 10.1002/clc.22537.
    PubMed     Text format    


  92. ZHU WG, Wan R, Din Y, Xu Z, et al
    Sex Differences in the Association Between Regular Physical Activity and Incident Atrial Fibrillation: A Meta-analysis of 13 Prospective Studies.
    Clin Cardiol. 2016 Mar 21. doi: 10.1002/clc.22531.
    PubMed     Text format     Abstract available


  93. BREUCKMANN F, Olligs J, Hinrichs L, Koopmann M, et al
    Coronary Artery Calcium as an Independent Surrogate Marker in the Risk Assessment of Patients With Atrial Fibrillation and an Intermediate Pretest Likelihood for Coronary Artery Disease Admitted to a German Chest Pain Unit.
    Clin Cardiol. 2016;39:157-64.
    PubMed     Text format     Abstract available


  94. SAAD M, Mahmoud A, Elgendy IY, Richard Conti C, et al
    Ranolazine in Cardiac Arrhythmia.
    Clin Cardiol. 2016;39:170-8.
    PubMed     Text format     Abstract available


    February 2016
  95. O'NEAL WT, Efird JT, Judd SE, McClure LA, et al
    Impact of Awareness and Patterns of Nonhospitalized Atrial Fibrillation on the Risk of Mortality: The Reasons for Geographic And Racial Differences in Stroke (REGARDS) Study.
    Clin Cardiol. 2016 Feb 16. doi: 10.1002/clc.22501.
    PubMed     Text format     Abstract available


  96. WUTZLER A, von Ulmenstein S, Attanasio P, Huemer M, et al
    Where There's Smoke, There's Fire? Significance of Atrial Fibrillation in Young Patients.
    Clin Cardiol. 2016 Feb 5. doi: 10.1002/clc.22516.
    PubMed     Text format     Abstract available


  97. HUEMER M, Meloh H, Attanasio P, Wutzler A, et al
    The Lewis Lead for Detection of Ventriculoatrial Conduction Type.
    Clin Cardiol. 2016;39:126-31.
    PubMed     Text format     Abstract available


  98. JACKSON LR 2ND, Kim SH, Piccini JP Sr, Gersh BJ, et al
    Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry.
    Clin Cardiol. 2016;39:119-25.
    PubMed     Text format     Abstract available


    January 2016
  99. PATEL NJ, Edla S, Deshmukh A, Nalluri N, et al
    Gender, Racial, and Health Insurance Differences in the Trend of Implantable Cardioverter-Defibrillator (ICD) Utilization: A United States Experience Over the Last Decade.
    Clin Cardiol. 2016 Jan 22. doi: 10.1002/clc.22496.
    PubMed     Text format     Abstract available


    June 2015
  100. BERTOMEU-GONZALEZ V, Anguita M, Moreno-Arribas J, Cequier A, et al
    Quality of Anticoagulation With Vitamin K Antagonists.
    Clin Cardiol. 2015;38:357-64.
    PubMed     Text format     Abstract available


    May 2015
  101. MASRUR S, Memon S, Thompson PD
    Brugada syndrome, exercise, and exercise testing.
    Clin Cardiol. 2015;38:323-6.
    PubMed     Text format     Abstract available


    April 2015
  102. SAURAV A, Smer A, Abuzaid A, Bansal O, et al
    Premature ventricular contraction-induced cardiomyopathy.
    Clin Cardiol. 2015;38:251-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: